Breaking News

Healthpoint Ltd to Pay $1 Mln to Massachusetts to Settle Marketing of Xenoderm Matter
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)
Loading...

On Friday, Massachusetts Attorney General Martha Coakley said Massachusetts had reached a settlement with Healthpoint and its general partner DFB Pharmaceuticals Inc as part of a broader national settlement of $48 million.

The settlement was to resolve allegations of wrongfully charging Medicaid and Medicare for the Xenaderm ointment though it was not approved by the FDA. According to Coakley, Massachusetts would be receiving $996,000. She said in a statement, “This settlement demonstrates the importance of policing the pharmaceutical industry and remaining vigilant with respect to drug marketing misconduct.”

However, the Texas-based Healthpoint has not admitted to any wrongdoing.

  
What
Where


The national-level settlement had been announced by the DOJ in December last year, over the complaint it had filed under the False Claims Act in 2011. The complaint had filed against Healthpoint in the District of Masschusetts.

According to the complaint by the U.S. Justice Department, Healthpoint had submitted false statements about Xenaderm to get Medicaid and Medicare money. The active ingredient in Xenaderm was found ineffective by the FDA back in the 70s, and prosecutors alleged that Healthpoint had acted with full knowledge that the ingredient, trypsin, was not approved by FDA.

In December, 2012, Healthpoint agreed to a settlement of up to $33 million with 47 states and $15 million for payment to the Medicare prescription drug benefit program.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!




Healthpoint is by no means alone in such practices. A number of companies, starting with Eon Labs in 2010, have been cornered by the DOJ over false claims. Eon paid $3.5 million to resolve things. In October 2012, the FDA issued an order prohibiting more than four thousand online pharmacies from selling FDA unapproved drugs.

Xenoderm was marketed for the treatment of bed sores and other sores caused by pressure.





 

RELEVANT JOBS

Paralegal / Legal Assistant

USA-NY-Staten Island

STATEN ISLAND PLAINTIFFS PERSONAL INJURY LAW FIRM IS SEEKING A FULL TIME/PART TIME PARALEGAL/LE...

Apply now

Attorney

USA-WA-Walla Walla

When the COVID crisis hit our state, we continued serving clients in our community. We are...

Apply now

Associate Attorney

USA-FL-Orlando

A/V Rated Downtown Orlando Law firm of Fisher Rushmer, P.A. is seeking an associate with 2 - 6 years...

Apply now

Legal Extern / Litigation Law Clerk

USA-VA-Alexandria

Old Towne Associates, P.C. (Alexandria, VA) Legal Extern Openings - Class of 2021 and 2022 ...

Apply now

BCG FEATURED JOB

Locations:

Keyword:



Search Now

Mergers and Acquisitions Associate Attorney

USA-CA-San Diego

San Diego office of a BCG Attorney Search top ranked law firm seeks Mergers and Acquisitions Associa...

Apply Now

Senior Wealth Management Group Associate Attorney

USA-CA-San Diego

San Diego office of our client seeks Senior Wealth Management Group Associate Attorney with 9 years ...

Apply Now

Bankruptcy Associate Attorney

USA-CA-Los Angeles

Los Angeles office of a BCG Attorney Search top ranked law firm seeks Bankruptcy Associate Attorney ...

Apply Now

Most Popular

SEARCH IN ARCHIVE

To Top